Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis

AIMS: The cardioprotective effects of glucose‐lowering medications in diabetic patients with heart failure (HF) are well known. Several large randomized controlled trials (RCTs) have recently suggested that the cardioprotective effects of glucose‐lowering medications extend to HF patients regardless...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeong, Trevor, Mai, Aaron Shengting, Lim, Oliver Z.H., Ng, Cheng Han, Chin, Yip Han, Tay, Phoebe, Lin, Chaoxing, Muthiah, Mark, Khoo, Chin Meng, Dalakoti, Mayank, Loh, Poay‐Huan, Chan, Mark, Yeo, Tiong‐Cheng, Foo, Roger, Wong, Raymond, Chew, Nicholas W.S., Lin, Weiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934935/
https://www.ncbi.nlm.nih.gov/pubmed/35092176
http://dx.doi.org/10.1002/ehf2.13822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934935/
https://www.ncbi.nlm.nih.gov/pubmed/35092176
http://dx.doi.org/10.1002/ehf2.13822

Ejemplares similares